Our published immunoblotting studies indicated elevated APLP2 expression in human pancreatic cancer cells, and by immunohistochemistry we had demonstrated increased APLP2 presence in primary human pancreatic tumors and metastases relative to the normal pancreas [6,10]. Here, APLP2 is linked to familial pancreatic carcinoma.